Kuehn Law Encourages Investors of Immunovant, Inc. to Contact Law Firm
NEW YORK, Oct. 12, 2026 /PRNewswire/ -- Kuehn Law, PLLC, a shareholder litigation law firm, is investigating whether certain officers and directors of Immunovant, Inc. (NASDAQ: IMVT) breached their fiduciary duties to shareholders. The investigation concerns potential self-dealing....
Covered in this story
Call it yourself
No calls on $IMVT yet. A scorecard is a price target with a date and the working behind it — tracked, settled and scored in public.
Make the first call on Immunovant Inc →Summary aggregated from PR Newswire's public RSS feed. The full reporting belongs to PR Newswire — please read it on their site.